Peptide, Protein and Vaccine Delivery

Track Chair(s)

• 

  Daniel Gallego-Perez, PhD (he/him/his)

  Associate Professor; Department of Biomedical Engineering and Surgery
  The Ohio State University
  Columbus, Ohio, United States

Moderator(s)

• 

  Ana Salazar-Puerta, PhD (she/her/hers)

  Postdoctoral Scholar
  The Ohio State University, United States
• 

  Tatiana Cuellar-Gaviria, PhD (she/her/hers)

  Postdoctoral Fellow
  The Ohio State University
  Columbus, Ohio, United States

Presentations:

• 12:30 PM – 12:45 PM PDT

  Albumin-binding nanobody-antigen fusions enhance antigen presentation and improve vaccine responses through pharmacokinetic modulation
  

  Presenting Author: Hayden M. Pagendarm, B.S. – Vanderbilt University

  Co-Author: Blaise Kimmel – Vanderbilt University

  Co-Author: Alexander J. Kwiatkowski, PhD – Vanderbilt University

  Primary Investigator: John T. Wilson, Ph.D. – Vanderbilt University
• 12:45 PM – 1:00 PM PDT

  Harnessing covalently tethered protein L-based blocking peptides to control antibody function
  

  Presenting Author: Michael I. Henderson, B.A. (he/him/his) – Oregon Health & Science University

  Co-Author: Michael Brasino, Ph.D. – Oregon Health and Science University

  Co-Author: Randall Armstrong, B.S. – Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University

  Co-Author: Eli Wagnell, B.S. – Oregon Health and Science University

  Primary Investigator: Stuart Ibsen, Ph.D. – Department of Biomedical Engineering, School of Medicine, Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University
• 1:00 PM – 1:15 PM PDT

  Understanding the Adjuvanticity of Co-Assembled Peptide Hydrogels for Biotherapeutic Delivery
  

  Presenting Author: Lucas Melgar, M.S. (he/him/his) – University of Florida

  Co-Author: Bethsymarie Soto-Morales – University of Florida

  Primary Investigator: Gregory Hudalla – University of Florida
• 1:15 PM – 1:30 PM PDT

  Novel ionic liquid adjuvant promotes a robust and antigen-specific Th1 response with biocompatible and GRAS materials
  

  Presenting Author: Morgan Goetz (she/her/hers) – Harvard University

  Co-Author: Charles Park (he/him/his) – Harvard University

  Co-Author: Alex Gottlieb (he/him/his) – Harvard University

  Co-Author: Maithili Joshi (she/her/hers) – Harvard University

  Last Author: Samir Mitragotri – Harvard University
• 1:30 PM – 2:00 PM PDT

  A Fade-Away Swish for Glioblastoma Treatment: Chemotherapy and Immunotherapy Delivery with Acetalated Dextran Scaffolds
  

  Presenting Author: Kristy Ainslie, PhD (she/her/hers) – University of North Carolina at Chapel Hill